Navigation Links
Human Genome Sciences Announces Third Quarter 2007 Financial Results and Key Developments
Date:11/1/2007

- Albuferon Phase 3 trials complete enrollment two months ahead of schedule

- - Progress continues on LymphoStat-B, ABthrax and TRAIL receptor antibody

programs -

- 2007 net cash burn on track for $145-165 million -

ROCKVILLE, Md., Nov. 1 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced financial results and key developments for the quarter ended September 30, 2007.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO )

"We are making good progress with our Phase 3 clinical trials of Albuferon(R) in patients with chronic hepatitis C and LymphoStat-B(R) in patients with lupus," said H. Thomas Watkins, President and Chief Executive Officer. "We completed enrollment of both of our Albuferon Phase 3 trials ahead of schedule. Enrollment of LymphoStat-B Phase 3 trials is progressing, and we expect to complete enrollment in 2008. We have met all milestones to date under our $165 million contract to supply ABthrax(TM) to the U.S. Strategic National Stockpile. Our cash position remains strong, and we are moving steadily toward commercialization."

HGS reported that net cash burn for the nine months ended September 30, 2007 totaled $81.2 million, net of $87.5 million in milestone payments received from Novartis.

"Even with the early full enrollment of the two Albuferon Phase 3 trials, we continue to expect net cash burn for 2007 in the range of $145-165 million," said Tim Barabe, Senior Vice President and Chief Financial Officer. "Our focus on controlling net cash burn is an important ongoing
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Human Primary Preadipocytes and Differentiated Adipocytes
2. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
3. Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance
4. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
5. Human Universal cDNA Library Array I
6. Map and Link Human Genetic Disorders with SSLP Analysis
7. RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes
8. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
9. Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations
10. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
11. Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression Vector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... NEW YORK , Dec. 23, 2014  NeuroLifeSciences ... of mazindol in children with attention deficit/hyperactivity disorder published ... 2014 . The paper, titled "Pilot ... deficit/hyperactivity disorder" ( Konofal et al, Drug ... 2014 ) shows that mazindol might be an ...
(Date:12/22/2014)... 22, 2014  Alternative Energy & Environmental Solutions, ... signed a letter of intent to acquire BioTechPharma ... patented a nanotechnology-based development platform used to create ... rapid on-site collection and testing to identify infectious ... in an immediate, non-invasive and cost-effective manner. ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 ITRA Global, ... and occupiers of commercial real estate, has further expanded ... offices in Perth and Brisbane, Western Australia, reports Mylinda ... directors. , ITRA Global / ACORPP (Australian Corporate ... independent consultancy company providing property services to a wide ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one of ... Nick Maroulis, Pharm.D. to the newly created position of ... this position, Dr. Maroulis will continue to manage the ... our multi-site pharmacies as the company expands. Dr. Maroulis ... time he has served in many different capacities in ...
Breaking Biology Technology:Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3ALNE Announces Intention To Acquire BioTechPharma 2ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2
... Coverage With Regional Perspective, PHILADELPHIA and LONDON, ... of information solutions to the worldwide,research and business ... have been added to Web of Science. The ... regional rather than,international audience by approaching subjects from ...
... Sciences, Inc. (OTC Bulletin Board: EROX) ("HPS" or "the,Company") ... year ended,December 31, 2007. For the three months ended ... decrease from revenues of $412,000,in the prior year period, ... as compared with a net income of $66,000 ($.02 ...
... N.Y., March 31 Chem Rx,Corporation (OTC Bulletin ... pharmacy services, announced today that it will hold ... discuss 2008 outlook,on April 1, 2008 at 8:30 ... and Steven C. Silva, President and Chief Operating,Officer, ...
Cached Biology Technology:Thomson Scientific Begins Expansion of Web of Science 2Human Pheromone Sciences Announces Quarterly and Full Year Results 2Human Pheromone Sciences Announces Quarterly and Full Year Results 3Human Pheromone Sciences Announces Quarterly and Full Year Results 4Chem Rx Corporation Schedules Conference Call to Review Full Year 2007 Financial Results 2
(Date:12/22/2014)... 2014 Research and Markets ... of the "The Global Watermarking and ... http://photos.prnewswire.com/prnh/20130307/600769 ... of the global digital media watermarking and ... monitor piracy by securely and invisibly embedding ...
(Date:12/19/2014)... DUBLIN , Dec. 18, 2014 Research ... announced the addition of the "iPhone 5S ... Technology Report" report to their offering. ... Following the acquisition of AuthenTec in July 2012, ... iPhone 5S. It is currently the only device ...
(Date:12/19/2014)...  23andMe, Inc., the leading personal genetics company, today ... differences in genetic ancestry of individuals from across ... immigrants first arrived more than four hundred years ago, ... as a meeting place for peoples from different continents. ... mixing of peoples with African, European, and American origins ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4
... that it was published in the Medical Hypotheses journal, ... analysis based on animal studies suggests that showering in ... permanent effects on the nervous system. The damage may ... the Environmental Protection Agency, according to researchers from Wake ...
... female monkeys at the Tulane National Primate Research Center ... anti-viral agents in a vaginal gel protect the animals ... microbicide using compounds that inhibit the processes by which ... provide a safe, effective and practical way to prevent ...
... Global Information System will provide valuable information for assessing ... of Environmental Health Sciences (NIEHS), one of the National ... most up-to-date data to public health and safety workers ... as well as demographic information for local populations. ...
Cached Biology News:Does manganese inhaled from the shower represent a public health threat? 2Does manganese inhaled from the shower represent a public health threat? 3Vaginal gel may provide a new approach to HIV prevention 2FDA approves child-friendly AIDS medicine 2
Anti-MMP-19 (RASI), carboxy terminal region; rabbit host...
Sheep polyclonal to hCG beta core fragment ( Abpromise for all tested applications). Antigen: Full length native protein (purified) from human urine. Entrez GeneID: 1082 Swiss Protein ID...
Evolutionarily conserved signaling intermediate in Toll pathway...
Anti-MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region; rabbit host...
Biology Products: